Robert Joseph Ball Purchases 2,000 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) CEO Robert Joseph Ball acquired 2,000 shares of the business’s stock in a transaction dated Thursday, September 11th. The stock was acquired at an average cost of $14.90 per share, with a total value of $29,800.00. Following the completion of the transaction, the chief executive officer owned 105,259 shares of the company’s stock, valued at approximately $1,568,359.10. The trade was a 1.94% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Robert Joseph Ball also recently made the following trade(s):

• On Friday, September 12th, Robert Joseph Ball acquired 6,000 shares of Shoulder Innovations stock. The stock was acquired at an average cost of $15.49 per share, with a total value of $92,940.00.

Shoulder Innovations Stock Up 5.0%

NYSE:SI opened at $15.68 on Wednesday. The company has a market cap of $238.81 million and a P/E ratio of -0.52. Shoulder Innovations, Inc. has a 1-year low of $11.75 and a 1-year high of $17.94.

Analyst Ratings Changes

SI has been the subject of several research reports. Morgan Stanley initiated coverage on Shoulder Innovations in a report on Monday, August 25th. They set an “overweight” rating and a $18.00 price target for the company. The Goldman Sachs Group initiated coverage on Shoulder Innovations in a report on Monday, August 25th. They set a “buy” rating and a $20.00 price target for the company. Zacks Research raised Shoulder Innovations to a “hold” rating in a report on Tuesday, August 26th. Piper Sandler initiated coverage on Shoulder Innovations in a report on Monday, August 25th. They set an “overweight” rating and a $18.00 price target for the company. Finally, Wall Street Zen raised Shoulder Innovations from a “sell” rating to a “hold” rating in a report on Saturday. Five analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $19.60.

About Shoulder Innovations

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.